Drug Profile
Progesterone gel - Catalent
Alternative Names: COL-1620; Crinone; Crinone 4%; Crinone 8%; Crinone8%; OneCrinone; Prochieve; Prochieve4%; Prochieve8%; progesterone vaginal gel 4%; progesterone vaginal gel 8%Latest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Columbia Laboratories
- Developer AbbVie; Actavis; Juniper Pharmaceuticals; Merck KGaA
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Amenorrhoea; Dysmenorrhoea; Female infertility; Menopausal syndrome; Menstruation disorders; Premenstrual syndrome
- Discontinued Preterm labour
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 03 Jul 2019 Progesterone gel is not yet available for Female infertility in Iceland and Slovenia
- 03 Jul 2019 Launched for Female infertility in Bulgaria, Estonia, France, Latvia, Lithuania, Romania, Croatia prior July 2019 (Vaginal)